Sino Biopharmaceutical Ltd (SBHMY)
7.20
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
Sino Biopharmaceutical Shareholders Equity (Quarterly): 4.299B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 4.299B |
June 30, 2023 | 4.134B |
June 30, 2023 | 4.134B |
December 31, 2022 | 4.312B |
June 30, 2022 | 4.508B |
June 30, 2022 | 4.508B |
June 30, 2021 | 3.801B |
June 30, 2021 | 3.801B |
March 31, 2021 | 2.836B |
December 31, 2020 | 2.563B |
September 30, 2020 | 4.640B |
June 30, 2020 | 4.444B |
June 30, 2020 | 4.444B |
March 31, 2020 | 4.459B |
December 31, 2019 | 2.137B |
September 30, 2019 | 4.292B |
June 30, 2019 | 4.345B |
March 31, 2019 | 4.420B |
December 31, 2018 | 1.893B |
September 30, 2018 | 3.013B |
June 30, 2018 | 3.062B |
March 31, 2018 | 3.192B |
December 31, 2017 | 1.411B |
September 30, 2017 | 1.373B |
June 30, 2017 | 1.274B |
Date | Value |
---|---|
March 31, 2017 | 1.224B |
December 31, 2016 | 1.138B |
September 30, 2016 | 1.129B |
June 30, 2016 | 1.079B |
March 31, 2016 | 1.060B |
December 31, 2015 | 999.80M |
September 30, 2015 | 981.23M |
June 30, 2015 | 944.73M |
March 31, 2015 | 895.52M |
December 31, 2014 | 852.18M |
September 30, 2014 | 806.68M |
June 30, 2014 | 746.47M |
March 31, 2014 | 724.64M |
December 31, 2013 | 707.50M |
September 30, 2013 | 676.61M |
June 30, 2013 | 637.29M |
March 31, 2013 | 620.23M |
December 31, 2012 | 591.08M |
September 30, 2012 | 548.05M |
June 30, 2012 | 515.64M |
December 31, 2011 | 490.52M |
September 30, 2011 | 458.42M |
June 30, 2011 | 463.06M |
March 31, 2011 | 471.22M |
June 30, 2010 | 449.37M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
2.137B
Minimum
Dec 2019
4.640B
Maximum
Sep 2020
3.980B
Average
4.299B
Median
Dec 2023
Shareholders Equity (Quarterly) Benchmarks
Global Pharmatech Inc | -- |
HUTCHMED (China) Ltd | 730.54M |
Pharmaron Beijing Co Ltd | 1.595B |
Regencell Bioscience Holdings Ltd | 12.03M |
Prenetics Global Ltd | 206.36M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 8.973B |
Total Liabilities (Quarterly) | 3.588B |
Debt to Equity Ratio | 0.4007 |
Current Ratio | 1.053 |
Net Debt Paydown Yield | 0.04% |